NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

Clinical trial NCT07309289 · RECRUITING

Trial details

NCT number: NCT07309289
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer (CRC)

Start date: 2025-07-01
Primary completion: 2029-03-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.